These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35085661)

  • 21. Sepsis During Immunosuppression for Sight-threatening Uveitis: The Flip side.
    Jones N
    Ocul Immunol Inflamm; 2018; 26(2):324-327. PubMed ID: 27540908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Uveitic macular edema and the pharmacotherapy].
    Liu X; Zhang M
    Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):151-4. PubMed ID: 25908007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in Polish patients treated for non-infectious uveitis.
    Waszczyk-Łączak M; Łazicka-Gałecka M; Chomicz L; Mucha K; Pączek L; Szaflik JP
    Ann Agric Environ Med; 2020 Dec; 27(4):644-649. PubMed ID: 33356073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of patients with birdshot retinochoroidopathy treated with systemic immunosuppression.
    Becker MD; Wertheim MS; Smith JR; Rosenbaum JT
    Ocul Immunol Inflamm; 2005; 13(4):289-93. PubMed ID: 16159719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: A cohort study.
    Keyes E; Jobanputra A; Feng R; Grinnell M; Vazquez T; Diaz D; Werth VP
    J Am Acad Dermatol; 2022 Aug; 87(2):447-448. PubMed ID: 34537250
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of utilization, cost and prescription trends of mycophenolate mofetil and methotrexate among medicare patients.
    Wang Y; Jorizzo J
    J Dermatolog Treat; 2022 May; 33(3):1798-1799. PubMed ID: 33554688
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of chronic non-infectious uveitis and scleritis.
    Rossi DC; Ribi C; Guex-Crosier Y
    Swiss Med Wkly; 2019 Feb; 149():w20025. PubMed ID: 30852832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate versus Methotrexate in Non-infectious Ocular Inflammatory Disease: A Systematic Review and Meta-Analysis.
    Karam M; Alsaif A; Al-Naseem A; Hayre A; Al Jabbouri A; Aldubaikhi A; Kahlar N; Al-Mutairi S
    Ocul Immunol Inflamm; 2023 Apr; 31(3):613-620. PubMed ID: 35201968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine Therapy in Sarcoidosis-Associated Uveitis.
    Bert A; El Jammal T; Kodjikian L; Gerfaud-Valentin M; Jamilloux Y; Seve P
    Ocul Immunol Inflamm; 2024 Feb; 32(2):154-160. PubMed ID: 36749910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome.
    Hervier B; Masseau A; Mussini JM; Audrain M; Hamidou MA
    Joint Bone Spine; 2009 Oct; 76(5):575-6. PubMed ID: 19464224
    [No Abstract]   [Full Text] [Related]  

  • 31. The safety and efficacy of noncorticosteroid triple immunosuppressive therapy in the treatment of refractory chronic noninfectious uveitis in childhood.
    Little JA; Sen ES; Strike H; Hinchcliffe A; Guly CM; Lee RW; Dick AD; Ramanan AV
    J Rheumatol; 2014 Jan; 41(1):136-9. PubMed ID: 24085549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.
    Shen E; Rathinam SR; Babu M; Kanakath A; Thundikandy R; Lee SM; Browne EN; Porco TC; Acharya NR
    Am J Ophthalmol; 2016 Aug; 168():279-286. PubMed ID: 27296490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
    Zierhut M; Stübiger N; Aboalchamat W; Landenberger H; Bialasiewicz AA; Engelmann K
    Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil as an immunomodulator in refractory noninfectious uveitis.
    Rodriguez EE; Sakata VM; Cavalcanti DC; Zaghetto JM; Olivalves E; Hirata CE; Yamamoto JH
    Arq Bras Oftalmol; 2016; 79(6):369-372. PubMed ID: 28076562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycophenolate mofetil in animal models of autoimmune disease.
    Zandman-Goddard G; Shoenfeld Y
    Lupus; 2005; 14 Suppl 1():s12-6. PubMed ID: 15803926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil in the treatment of uveitis in children.
    Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
    Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil for the treatment of uveitis.
    Teoh SC; Hogan AC; Dick AD; Lee RW
    Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil monotherapy in the management of paediatric uveitis.
    Chang PY; Giuliari GP; Shaikh M; Thakuria P; Makhoul D; Foster CS
    Eye (Lond); 2011 Apr; 25(4):427-35. PubMed ID: 21423146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.